JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules

/PRNewswire/ -- JanOne (Nasdaq: JAN) (the "Company"), a biopharmaceutical company specializing in developing non-addicting pain killers and treatments for...

Related Keywords

New York ,United States , ,Hc Wainwright Co ,Janone Inc ,Exchange Commission ,Nasdaq ,Securities Act ,Private Securities Litigation Reform Act ,